Third Point Files 13D Activist Stake in Strata Critical Medical

Third Point has transitioned from a passive 13G filing to an activist 13D position regarding its investment in Strata Critical Medical (SRTA). The firm acquired 170,011 shares between August 31 and October 13, 2026, at prices between $4.53 and $5.66, while selling 43,500 shares in the same timeframe. Third Point believes that SRTA's stock is undervalued and sees potential in the company's business.